Study #2023-0828
Open label single arm pilot trial of Letermovir for cytomegalovirus prophylaxis after axicabtagene ciloleucel therapy
MD Anderson Study Status
Enrolling
Treatment Agent
Letermovir
Description
The goal of this clinical research study is to learn if a drug called Letermovir can help to prevent CMV reactivation.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Cell Therapy
Study phase:
Phase II
Physician name:
George Chen
Department:
Stem Cell Transplantation
For general questions about clinical trials:
1-844-513-2253
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.